Chugai OTC Stock Valuation

CHGCF
 Stock
  

USD 27.73  0.00  0.00%   

What is the value of Chugai Pharmaceutical today? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Chugai Pharmaceutical, is its stock price multiplied by the total number of shares outstanding, calculating Chugai Pharmaceutical's enterprise value requires a different approach. It uses Chugai Pharmaceutical's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Chugai Pharmaceutical shows a prevailing Real Value of $27.51 per share. The current price of the firm is $27.73. At this time, the firm appears to be fairly valued. Our model approximates the value of Chugai Pharmaceutical from analyzing the firm fundamentals such as Current Valuation of (546.63 B), profit margin of 32.26 %, and Return On Equity of 32.97 % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor purchasing undervalued instruments and exiting overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
  
Chugai Pharmaceutical Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Chugai Pharmaceutical's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.
Fairly Valued
Today 27.73
Please note that Chugai Pharmaceutical's price fluctuation is very steady at this time. Calculation of the real value of Chugai Pharmaceutical is based on 3 months time horizon. Increasing Chugai Pharmaceutical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Chugai Pharmaceutical is useful when determining the fair value of the Chugai otc stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Chugai Pharmaceutical. Since Chugai Pharmaceutical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Chugai OTC Stock. However, Chugai Pharmaceutical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
27.51
Real Value
27.92
Upside
Estimating the potential upside or downside of Chugai Pharmaceutical helps investors to forecast how Chugai otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Chugai Pharmaceutical more accurately as focusing exclusively on Chugai Pharmaceutical's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimated ValueHigh
27.3227.7328.14
Details

Chugai Pharmaceutical Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Chugai Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Chugai Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Chugai Pharmaceutical competition to find correlations between indicators driving Chugai Pharmaceutical's intrinsic value. More Info.
Chugai Pharmaceutical is number one stock in price to book category among related companies. It is number one stock in last dividend paid category among related companies creating about  13.20  of Last Dividend Paid per Price to Book. . Comparative valuation analysis is a catch-all model that can be used if you cannot value Chugai Pharmaceutical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Chugai Pharmaceutical's OTC Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Chugai Pharmaceutical's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Chugai Pharmaceutical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Chugai Pharmaceutical and how it compares across the competition.

About Chugai Pharmaceutical Valuation

The otc valuation mechanism determines the current worth of Chugai Pharmaceutical on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Chugai Pharmaceutical. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Chugai Pharmaceutical based exclusively on its fundamental and basic technical indicators. By analyzing Chugai Pharmaceutical's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Chugai Pharmaceutical's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Chugai Pharmaceutical. We calculate exposure to Chugai Pharmaceutical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Chugai Pharmaceutical's related companies.
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd. Chugai Pharmaceutical operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 7664 people.
Chugai Pharmaceutical's stock price is the clearest measure of market expectations about its performance. Without stock valuation, investors cannot independently discern whether Chugai Pharmaceutical's value is low or high relative to the company's performance and growth projections. Determining the market value of Chugai Pharmaceutical can be done in different ways, such as multiplying its stock price by its outstanding shares.
A single share of Chugai Pharmaceutical represents a small ownership stake in the entity. As a stockholder of Chugai, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.

Chugai Pharmaceutical Dividends Analysis For Valuation

There are various types of dividends Chugai Pharmaceutical can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Chugai shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Chugai Pharmaceutical directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Chugai pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Chugai Pharmaceutical by the value of the dividends paid out.

Chugai Pharmaceutical Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Chugai Pharmaceutical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quick Ratio2.92
Earnings Quarterly Growth2.30%
Revenue Growth6.40%
Payout Ratio35.53%
Enterprise Value To Ebitda-0.95
Earnings Growth2.30%
Enterprise Value To Revenue-0.45
Continue to Trending Equities. Note that the Chugai Pharmaceutical information on this page should be used as a complementary analysis to other Chugai Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fund Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for Chugai OTC Stock analysis

When running Chugai Pharmaceutical price analysis, check to measure Chugai Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chugai Pharmaceutical is operating at the current time. Most of Chugai Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Chugai Pharmaceutical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chugai Pharmaceutical's price. Additionally, you may evaluate how the addition of Chugai Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Is Chugai Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chugai Pharmaceutical. If investors know Chugai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chugai Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Chugai Pharmaceutical is measured differently than its book value, which is the value of Chugai that is recorded on the company's balance sheet. Investors also form their own opinion of Chugai Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Chugai Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chugai Pharmaceutical's market value can be influenced by many factors that don't directly affect Chugai Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chugai Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine Chugai Pharmaceutical value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chugai Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.